Evidence mapPaperPMID 22029981Full record

Trial reportThe New England journal of medicine2011

Long-term persistence of hormonal adaptations to weight loss.

Priya Sumithran, Luke A Prendergast, Elizabeth Delbridge, Katrina Purcell, Arthur Shulkes, Adamandia Kriketos, Joseph Proietto

8 registry-linked trialsAbstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in The New England journal of medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 8 registered trials, which are not on this map. Cited by 595 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
595citing papers in PubMed, 9 pooled it
29.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02798744 phase4completedstarted 2016, after this paper: background citation

SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation: A Randomised Double-blind Placebo-controlled Trial (The SEESAW Study)

Ran2016Enrolled68Registered outcomes15Posted comparisons0ConditionsDiabetes Mellitus, Type 2Armsdiet, empagliflozin, Placebo
Open the trial in the graph
NCT00870259 nacompletednot on this map

An Investigation of Physiological Adaptations Contributing to Weight Regain After Weight Loss

TypeinterventionalSponsorUniversity of MelbourneRan2008 to 2009Enrolled50ConditionsObesityArmsOptifast VLCD
NCT01849627 nacompletednot on this mapstarted 2014, after this paper: background citation

Eat Well for Life: A Weight Loss Maintenance Study

TypeinterventionalSponsorThe University of Tennessee, KnoxvilleRan2014 to 2025Enrolled345ConditionsObesityArmsLow-ED, Energy Balance
NCT02030249 naunknown statusnot on this mapstarted 2014, after this paper: background citation

Sub-Study of the PREVIEW Study Australia: Effects of Weight Loss on Appetite, Bone Mass and Muscle Strength

TypeinterventionalSponsorUniversity of SydneyRan2014 to 2021Enrolled292ConditionsPre-diabetes, ObesityArmsLow calorie diet administered from 0 to 2 months, High Protein / Low Glycaemic Index, Moderate Protein / High Glycaemic Index
NCT02542449 phase4completednot on this mapstarted 2013, after this paper: background citation

Placebo Controlled, Randomized, Single Blinded Trial on the Effects of Greenselect Phytosome® on Weight Maintenance in Obese Women After a 3-month Weight Loss Intervention

TypeinterventionalSponsorIstituto Auxologico ItalianoRan2013 to 2014Enrolled40ConditionsObesityArmsGlobes®, Placebo
NCT02683902 naunknown statusnot on this mapstarted 2016, after this paper: background citation

The Effect of Hypocaloric Diet Associated With tDCS on Weight Loss and Metabolic Profile: a Pilot, Double Blind, Randomized, Placebo-controlled Study

TypeinterventionalSponsorHospital de Clinicas de Porto AlegreRan2016 to 2018Enrolled20ConditionsPrediabetes, Obesity, Weight Loss, DiabetesArmsActive tDCS, Hypocaloric diet, Sham tDCS
NCT03396146 nacompletednot on this mapstarted 2018, after this paper: background citation

Assay for the Pancreatic Polypeptide: an Help for Clinical Practice Guidelines in Classification of the Diabetes

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2018 to 2019Enrolled36ConditionsType1diabetesArms12 ml total blood tubes volume, Fecal sample
NCT04306445 naterminatednot on this mapstarted 2020, after this paper: background citation

The Effect of a Gas-filled Intragastric Balloon or Endoscopic Sleeve Gastroplasty for Weight Loss Compared With a Meal Replacement Weight Loss Program on Gastric Emptying, Hormonal Adaptation to Weight Loss, and Hunger

TypeinterventionalSponsorUniversity of Colorado, DenverRan2020 to 2024Enrolled3ConditionsObesityArmsGF-IGB: Obalon Balloon, Medically Supervised Meal Replacement Program: My New Weigh, Endoscopic sleeve gastroplasty: (ESG)
3 · Its place in the literature

Who cites it

595 citing papers in PubMed, 9 syntheses or guidelines pooled it, 1,359 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Differences in gastrointestinal hormones and appetite ratings between individuals with and without obesity-A systematic review and meta-analysis.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2023
    Pooled it
  8. Obesity in South and Southeast Asia-A new consensus on care and management.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2023
    Guideline
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

535 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Priya SumithranDepartment of Medicine (Austin and Northern Health), University of Melbourne, Melbourne, VIC, Australia.
Luke A Prendergast
Elizabeth Delbridge
Katrina Purcell
Arthur Shulkes
Adamandia Kriketos
Joseph Proietto
University of Melbourne · AULa Trobe University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAfter weight loss, changes in the circulating levels of several peripheral hormones involved in the homeostatic regulation of body weight occur. Whether these changes are transient or persist over time may be important for an understanding of the reasons behind the high rate of weight regain after diet-induced weight loss.

methodsWe enrolled 50 overweight or obese patients without diabetes in a 10-week weight-loss program for which a very-low-energy diet was prescribed. At baseline (before weight loss), at 10 weeks (after program completion), and at 62 weeks, we examined circulating levels of leptin, ghrelin, peptide YY, gastric inhibitory polypeptide, glucagon-like peptide 1, amylin, pancreatic polypeptide, cholecystokinin, and insulin and subjective ratings of appetite.

resultsWeight loss (mean [±SE], 13.5±0.5 kg) led to significant reductions in levels of leptin, peptide YY, cholecystokinin, insulin (P<0.001 for all comparisons), and amylin (P=0.002) and to increases in levels of ghrelin (P<0.001), gastric inhibitory polypeptide (P=0.004), and pancreatic polypeptide (P=0.008). There was also a significant increase in subjective appetite (P<0.001). One year after the initial weight loss, there were still significant differences from baseline in the mean levels of leptin (P<0.001), peptide YY (P<0.001), cholecystokinin (P=0.04), insulin (P=0.01), ghrelin (P<0.001), gastric inhibitory polypeptide (P<0.001), and pancreatic polypeptide (P=0.002), as well as hunger (P<0.001).

conclusionsOne year after initial weight reduction, levels of the circulating mediators of appetite that encourage weight regain after diet-induced weight loss do not revert to the levels recorded before weight loss. Long-term strategies to counteract this change may be needed to prevent obesity relapse. (Funded by the National Health and Medical Research Council and others; ClinicalTrials.gov number, NCT00870259.).

Indexed as

Body Mass IndexBody WeightCholecystokininDiet, ReducingFemaleGastrointestinal HormonesGhrelinGlucagon-Like Peptide 1HumansIntention to Treat AnalysisLeptinMaleMiddle AgedObesityPeptidesPeptide YYCholecystokininGastrointestinal HormonesGhrelinGlucagon-Like Peptide 1LeptinPeptidesPeptide YY

Identifiers

PMID22029981
OpenAlexW2167222546

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

and 2 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.